Journal Article Summary
The article investigates the effectiveness and safety of a new topical minoxidil formulation, specifically a 5% cetosomal minoxidil solution, compared to the traditional 5% alcohol-based minoxidil solution for treating androgenetic alopecia (AGA) in Indian men. AGA is a common form of hair loss that can significantly affect individuals' psychological well-being and social interactions. The study is important because many patients using alcohol-based minoxidil experience side effects like scalp irritation and dryness, which can hinder treatment compliance and overall satisfaction.
In this randomized, open-label study, 80 adult men with mild-to-moderate AGA were divided into two groups to receive either the cetosomal or alcohol-based minoxidil solution twice daily for 16 weeks. Of the 80 participants, only 40 completed the study, and the results showed that 52% of those using cetosomal minoxidil experienced positive hair growth, compared to 24% in the alcohol-based group. While both formulations showed similar efficacy in improving hair growth, the cetosomal minoxidil group reported significantly fewer adverse events, with only 9% experiencing side effects compared to 41% in the alcohol-based group. Additionally, quality of life related to hair health improved more in the cetosomal group.
Despite the promising findings, the study has limitations, including a small sample size and a high dropout rate, likely influenced by the COVID-19 pandemic. Patients should be aware that while cetosomal minoxidil may be a safer option, the study's small scale means further research is needed to confirm these results. It is advisable for individuals considering these treatments to discuss their options with a healthcare professional, especially regarding any potential side effects and the best approach for their specific situation.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sattur Sandeep, Talathi Abhay, Shetty Geetanjali, Arsiwala Shehnaz, Pereira Rickson, Dhoot Dhiraj. Comparative Clinical Study Evaluating the Efficacy and Safety of Topical 5% Cetosomal Minoxidil and Topical 5% Alcohol-Based Minoxidil Solutions for the Treatment of Androgenetic Alopecia in Indian Men. Cureus 2023. DOI: 10.7759/cureus.46568. PMID: 37937040. PMCID: PMC10626207.
Featured Pill Pals Product
Minoxidil 2.5 mg Tablets --- Generic for Loniten - Par Pharma --- Par Pharma
Minoxidil 2.5 mg Tablets — Generic for Loniten – Par Pharma — Par Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
